Antibody responses to two-dose COVID-19 vaccination in people living with HIV
In a research study originally released as a preprint, and now published in npj vaccines, Drs. Zabrina Brumme and Mark Brockman, from the BC Centre for Excellence in HIV/AIDS and Simon Fraser University, evaluated antibody responses to COVID-19 vaccines in people living with HIV who were receiving suppressive antiretroviral therapy.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed